S
EW icon

Sachetta’s Edwards Lifesciences EW Stock Holding History

Sachetta’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-93
Closed -$7.45K – 1091
2026
Q1 		$7.45K Buy
93
+8
+9% +$660 ﹤0.01% 524
2025
Q4 		$7.25K Sell
85
-30
-26% -$2.46K ﹤0.01% 465
2025
Q3 		$8.94K Buy
115
+27
+31% +$2.11K ﹤0.01% 492
2025
Q2 		$6.88K Buy
88
+59
+203% +$4.4K ﹤0.01% 518
2025
Q1 		$2.1K Hold
29
– – ﹤0.01% 782
2024
Q4 		$2.15K Hold
29
– – ﹤0.01% 809
2024
Q3 		$1.91K Sell
29
-46
-61% -$3.34K ﹤0.01% 888
2024
Q2 		$4.77K Buy
75
+54
+257% +$4.78K ﹤0.01% 599
2024
Q1 		$1.6K Hold
21
– – ﹤0.01% 783
2023
Q4 		$1.6K Buy
+21
New +$1.46K ﹤0.01% 783

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

Sachetta's EW Position: Q2 2026 in Review

Sachetta sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 93 shares — an estimated $7.45K sold.

Sachetta first reported a position in EW in Q4 2023 and held it in 10 quarters. The position peaked at $8.94K in Q3 2025. 262 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Sachetta reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
  • Sachetta sold 93 Edwards Lifesciences shares in Q2 2026, an estimated $7.45K.
  • Sachetta first reported a position in Edwards Lifesciences in Q4 2023 and held it in 10 quarters.
  • Sachetta's Edwards Lifesciences position peaked at $8.94K in Q3 2025.
  • 262 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Sachetta's 13F filing for Q2 2026, filed 15 Jul 2026.